Whiteswell announces successful treatment of acute decompensated heart failure patients in its early feasibility delta-hf study

Galway, ireland--(business wire)--whiteswell, a company pioneering a new paradigm in the treatment of acute decompensated heart failure (adhf), announced today positive initial results from its ongoing delta-hf trial evaluating the whiteswell elym™ system. the data were presented at the heart failure society of america (hfsa) annual scientific meeting 2023 in cleveland, ohio. in delta-hf, a minimally invasive catheter-based system is introduced to facilitate the removal of excess fluid from the.
DAL Ratings Summary
DAL Quant Ranking